Jaffetilchin Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $436K | Buy |
888
+4
| +0.5% | +$2.17K | 0.03% | 292 |
|
|
2025
Q4 | $512K | Buy |
884
+2
| +0.2% | +$1.13K | 0.03% | 266 |
|
|
2025
Q3 | $428K | Sell |
882
-5
| -0.6% | -$2.33K | 0.03% | 303 |
|
|
2025
Q2 | $360K | Sell |
887
-26
| -3% | -$10.9K | 0.02% | 307 |
|
|
2025
Q1 | $454K | Buy |
913
+6
| +0.7% | +$3.25K | 0.03% | 260 |
|
|
2024
Q4 | $472K | Buy |
907
+15
| +2% | +$8.25K | 0.03% | 239 |
|
|
2024
Q3 | $552K | Hold |
892
| – | – | 0.04% | 213 |
|
|
2024
Q2 | $493K | Hold |
892
| – | – | 0.04% | 217 |
|
|
2024
Q1 | $518K | Buy |
892
+4
| +0.5% | +$2.25K | 0.05% | 206 |
|
|
2023
Q4 | $471K | Buy |
888
+2
| +0.2% | +$968 | 0.05% | 224 |
|
|
2023
Q3 | $448K | Sell |
886
-301
| -25% | -$160K | 0.05% | 211 |
|
|
2023
Q2 | $619K | Buy |
1,187
+295
| +33% | +$159K | 0.07% | 174 |
|
|
2023
Q1 | $514K | Sell |
892
-89
| -9% | -$50.2K | 0.06% | 198 |
|
|
2022
Q4 | $540K | Buy |
981
+2
| +0.2% | +$1.06K | 0.07% | 194 |
|
|
2022
Q3 | $497K | Sell |
979
-18
| -2% | -$10.1K | 0.06% | 178 |
|
|
2022
Q2 | $541K | Buy |
997
+5
| +0.5% | +$2.75K | 0.06% | 176 |
|
|
2022
Q1 | $521K | Sell |
992
-11
| -1% | -$6.32K | 0.06% | 181 |
|
|
2021
Q4 | $669K | Buy |
1,003
+36
| +4% | +$22.5K | 0.06% | 181 |
|
|
2021
Q3 | $552K | Sell |
967
-841
| -47% | -$462K | 0.06% | 190 |
|
|
2021
Q2 | $880K | Buy |
1,808
+721
| +66% | +$340K | 0.06% | 187 |
|
|
2021
Q1 | $496K | Buy |
1,087
+270
| +33% | +$129K | 0.06% | 197 |
|
|
2020
Q4 | $380K | Buy |
817
+94
| +13% | +$44.1K | 0.05% | 198 |
|
|
2020
Q3 | $319K | Sell |
723
-11
| -1% | -$4.54K | 0.06% | 181 |
|
|
2020
Q2 | $266K | Sell |
734
-284
| -28% | -$95.2K | 0.06% | 175 |
|
|
2020
Q1 | $289K | Buy |
1,018
+29
| +3% | +$9.14K | 0.1% | 125 |
|
|
2019
Q4 | $321K | Buy |
989
+206
| +26% | +$62.5K | 0.07% | 162 |
|
|
2019
Q3 | $228K | Sell |
783
-466
| -37% | -$133K | 0.05% | 198 |
|
|
2019
Q2 | $367K | Buy |
1,249
+465
| +59% | +$128K | 0.09% | 171 |
|
|
2019
Q1 | $215K | Sell |
784
-151
| -16% | -$37.6K | 0.05% | 266 |
|
|
2018
Q4 | $209K | Buy |
+935
| New | +$219K | 0.05% | 239 |
|
|
2015
Q4 | – | Sell |
-3,570
| Closed | -$437K | – | 223 |
|
|
2015
Q3 | $437K | Buy |
+3,570
| New | +$465K | 0.16% | 105 |
|
|
2014
Q2 | – | Sell |
-5,415
| Closed | -$651K | – | 235 |
|
|
2014
Q1 | $651K | Buy |
+5,415
| New | +$644K | 0.25% | 67 |
|
|
2013
Q4 | – | Sell |
-3,133
| Closed | -$289K | – | 202 |
|
|
2013
Q3 | $289K | Buy |
+3,133
| New | +$283K | 0.17% | 128 |
|
Other funds holding TMO
VCM
Jaffetilchin Investment Partners's TMO Position: Q1 2026 in Review
Jaffetilchin Investment Partners increased its Thermo Fisher Scientific (TMO) stake by 0.45% in Q1 2026, buying an estimated $2.17K and bringing the position to 888 shares worth $436K. The position accounts for 0.03% of the portfolio, ranked #292.
Jaffetilchin Investment Partners first reported a position in TMO in Q3 2013 and has held it in 33 quarters since. The position peaked at $880K in Q2 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Jaffetilchin Investment Partners held 888 shares of Thermo Fisher Scientific worth $436K as of Q1 2026.
- Jaffetilchin Investment Partners bought 4 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.17K.
- Thermo Fisher Scientific made up 0.03% of Jaffetilchin Investment Partners's portfolio in Q1 2026, its #292 holding.
- Jaffetilchin Investment Partners first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 33 quarters since.
- Jaffetilchin Investment Partners's Thermo Fisher Scientific position peaked at $880K in Q2 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.